Advancements in Pompe Disease Management New Long-Term Data for Pombiliti and Opfolda Makes Strides in Clinical Effic...
The landscape of Pompe disease management continues to evolve, with the presentation of new four-year data for Pombiliti (cipaglucosidase alfa-atga) in combination with Opfolda (miglustat) at the recent International Co...
Sep 8, 2025
• Major Pharmaceutical Preparations Industry
Clinical Study
Amicus Therapeutics
